Articulating the fraud in "Lyme Disease"- invalid methods of all sorts:

http://www.ilads.org/position2.html

"The study by Klempner et al. contains a series of interrelated errors. It fails to achieve its stated goal of being a long-term, properly randomized, placebo-controlled treatment trial. The study appears to be scientifically invalid and risks harming patients if its flawed conclusions are accepted uncritically by physicians. In view of the uninterpretable results of this study, further research into the use of long-term antibiotic therapy for chronic Lyme disease is warranted."

http://ActionLyme.com before updates completed 4/25/05.

Coming soon:  New Biomarkers of CNS disease, update to the Rhode Island Tick Borne Diseases Management Plan (April 2002).

http://www.actionlyme.com/RHODE_ISLAND.htm

http://www.Columbia-Lyme.org

http://www.ILADS.org

http://www.CanLyme.com/

http://www.MentalHealthandIllness.com

http://www.wildernetwork.org/

http://www.autisticadults.com/autism.htm

http://home.att.net/~ascaris1/ Best on the web

New for site (under construction, last edit 27 April 05)

Scientific Fraud:

"L2 Diagnostics, which was established with School of Medicine investment funds as a spin-off from its own Lyme/Lupus Diagnostics Laboratory. The new diagnostic methods developed by the laboratory will help distinguish patients infected with Lyme disease from those who have been vaccinated. In May, an FDA advisory panel recommended approval of a Yale-developed vaccine."

http://info.med.yale.edu/external/pubs/ym_su98/scope/scope_yale_02.html

Kathleen M. Dickson